Canadian Biopharma Co. Forms Multi-Level Strategic Partnership with Former NBA Great
Back in December, we introduced Stockhouse investors to a pioneering cannabinoid biopharmaceutical company making waves in the cannabis space. Avicanna Inc. is a Toronto-based biopharma company focused on commercialization of plant-derived and evidence-based cannabinoid products. Recently, the company announced that they had entered into an intellectual property licensing and royalty agreement with Harrington Wellness Inc. and CEO Al Harrington, a former NBA veteran of 16 years, for the development and licensing of a bespoke and evidence-based athletic line of CBD topical products for Harrington Wellness’ re+PLAY brand in the U.S. Stockhouse's Dave Jackson reports.
1. T.APHA | 116,722 views | Aphria Inc.
2. C.CBDT | 50,777 views | Empower Clinics Inc.
3. T.AH | 47,385 views | Aleafia Health Inc.
4. T.WEED | 45,709 views | Canopy Growth Corp.
5. T.HEXO | 45,026 views | HEXO Corp.
6. T.ZENA | 43,644 views | Zenabis Global Inc.
FULL DISCLOSURE: Avicanna Inc., Numinus Wellness Inc., and Sugarbud Craft Growers Corp. are clients of Stockhouse Publishing.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.